Analysts Set Astera Labs, Inc. (NASDAQ:ALAB) Price Target at $275.75

Shares of Astera Labs, Inc. (NASDAQ:ALABGet Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-three ratings firms that are currently covering the firm, MarketBeat.com reports. Eleven investment analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $282.00.

A number of analysts have recently commented on the stock. TD Cowen boosted their target price on shares of Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a report on Monday, July 13th. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Roth Capital reiterated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Finally, Morgan Stanley increased their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th.

Read Our Latest Analysis on Astera Labs

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer directly owned 3,929,183 shares in the company, valued at $786,465,269.28. This represents a 3.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,676,845 shares of company stock worth $444,928,806. Company insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently made changes to their positions in ALAB. Reflection Asset Management purchased a new position in Astera Labs in the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC lifted its position in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Aventura Private Wealth LLC bought a new position in Astera Labs during the fourth quarter valued at $33,000. Hilltop National Bank grew its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs in the 4th quarter worth $33,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Trading Down 1.2%

Shares of NASDAQ ALAB opened at $326.97 on Friday. The firm has a fifty day simple moving average of $357.77 and a two-hundred day simple moving average of $225.19. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a market capitalization of $56.05 billion, a PE ratio of 220.93, a price-to-earnings-growth ratio of 3.83 and a beta of 3.66.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts predict that Astera Labs will post 1.86 earnings per share for the current year.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.